Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Reneo Pharmaceuticals IncRPHM | +71.81% | $4.08 | $7.01 | 2022-09-18 - 2023-09-18 | Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Reneo Pharmaceuticals IncRPHM | 3 | Buy | $30.00 | +1,614.29% | Reiterates | 8 months ago |
Anaptysbio IncANAB | 1 | Buy | $35.00 | N/A | Assumes | 2 years ago |
Elevation Oncology IncELEV | 1 | Buy | $7.50 | N/A | Assumes | 2 years ago |
Immunic IncIMUX | 2 | Buy | $26.00 | N/A | Assumes | 2 years ago |
Prothena Corp Public Ltd CoPRTA | 1 | Buy | $77.00 | N/A | Initiates Coverage On | 3 years ago |
Protagonist Therapeutics IncPTGX | 4 | Buy | $70.00 | N/A | Maintains | 3 years ago |
Kaleido Biosciences IncKLDO | 1 | Buy | $22.00 | N/A | Maintains | 3 years ago |
Evelo Biosciences IncEVLO | 4 | Buy | $830.00 | N/A | Maintains | 3 years ago |